Landec Corp reports results for the quarter ended in August - Earnings Summary

Lifecore Biomedical

06/10/2022 14:31

* Landec Corp  LNDC.OQ  reported a quarterly adjusted loss
of 32
cents​​ per share for the quarter ended in August. The mean
expectation of three analysts for the quarter was for a loss
of 13 cents per share.
    * Revenue fell 66.3% to $43.36 million from a year ago;
analysts
expected $42.74 million. 
    * Landec Corp's reported EPS for the quarter was a loss
of 41
cents​.
    * The mean earnings estimate of analysts had fallen by
about 200%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Landec Corp shares had fallen by 2.1% this quarter and
lost 21.6% so far this year.
    * The company reported a quarterly loss of $12.06 million.
    * Wall Street's median 12-month price target for Landec Corp
is
$14.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data October 6
at 01:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Aug. 31 2022      -0.13          -0.32          Missed
 May. 31 2022      -0.01          -0.01          Met
 Feb. 28 2022      0.00           -0.08          Missed
 Nov. 30 2021      -0.04          0.05           Beat